MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

70 hedge funds and large institutions have $137M invested in Merrimack Pharmaceuticals, Inc. in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 9 closing their positions.

Holders
70
Holders Change
+3
Holders Change %
+4.48%
% of All Funds
1.01%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
12
Increased
15
Reduced
21
Closed
9
Calls
$1.87M
Puts
$47K
Net Calls
+$1.82M
Net Calls Change
+$218K

Top Buyers

1
ACM
1
ADAR1 Capital Management
Texas
$13.3M
2
Invesco
2
Invesco
Georgia
$4.09M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.4M
4
YCM
4
Yakira Capital Management
Connecticut
$1.78M
5
State Street
5
State Street
Massachusetts
$3.65M

Top Sellers

1
SCM
1
Sio Capital Management
New York
$0
2
ICM
2
Indaba Capital Management
California
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$583K
4
MAP
4
Madison Avenue Partners
New York
$5.72M
5
RA
5
Rosalind Advisors
Ontario, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Group One Trading
76
Group One Trading
Illinois
– -$3.17K -236 Closed
Federated Hermes
77
Federated Hermes
Pennsylvania
– -$1.14K -85 Closed
1 2 3
4